Negative impactResults

Reliance Industries Q2 Review: Motilal Oswal Cuts Target Price Despite Strongest Ebitda In 17 Quarters; Here's Why

NDTV Profit 3 hrs ago·2 Nov 2026, 2:55 am

Reliance Industries reported its strongest quarterly earnings in 17 quarters, largely driven by a surge in its energy and petrochemicals segments. This performance has led Motilal Oswal to maintain its positive stance on the company, even as they have lowered their target price for the stock. The brokerage's decision highlights the complex factors currently influencing the market's view of the conglomerate.

The primary reason for the target price cut is a cautious outlook on Reliance Retail Ventures. Investors are closely watching the recovery in the growth and profitability of this key business division. While the energy business is performing well, the stock price is heavily influenced by the retail segment's ability to regain its previous growth trajectory.

Investors should keep a close eye on Reliance's future quarterly updates, specifically regarding the turnaround in its retail operations. The stock's movement will likely depend on whether the company can successfully navigate the challenges in this sector, balancing the strong performance of its energy business with the expected recovery in retail.

Affected stocks

Bearish1 stock

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Reliance Industries (RELIANCE).
  • Category: Results.
  • AI reads the tone as negative (potentially bearish) for the stock.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update for Reliance Industries worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NDTV Profit.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.